Showing Results for
- Academic Journals (114)
Search Results
- 114
Academic Journals
- 114
- Search Terms:
- 1From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Numerous evidences suggest that diabetic heart is characterized by compromised ventricular contraction and prolonged relaxation attributable to multiple causative factors including calcium accumulation,...
- 2From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Although clinical diabetes mellitus is obviously a high risk factor for myocardial infarction (MI), in experimental studies disagreement exists about the sensitivity to ischemic injury of an infarcted...
- 3From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Although the ADA/EASD/IDF International Expert Committee recommends using hemoglobin A1c (HbA1c) to define diabetes, the relation between HbA1c and cardiovascular disease (CVD) has not been thoroughly...
- 4From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Leptin is associated with cardiovascular disease (CVD); however, few studies have assessed its relationship with metabolic syndrome, especially in an Asian population. Therefore, the aim of the present...
- 5From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Diabetic cardiomyopathy, a diabetes-specific complication, refers to a disorder that eventually leads to left ventricular hypertrophy in addition to diastolic and systolic dysfunction. In recent studies,...
- 6From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Given the elevated risk of cardiovascular events and the higher prevalence of silent coronary artery disease (CAD) in diabetic versus non-diabetic patients, the need to screen asymptomatic diabetic...
- 7From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Trichlormethiazide, a thiazide diuretic, was introduced in 1960 and remains one of the most frequently used diuretics for treating hypertension in Japan. While numerous clinical trials have indicated...
- 8From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground For patients with diabetes, clinical practice guidelines recommend treating to a low-density lipoprotein cholesterol (LDL-C) goal of [less than]2.59 mmol/L (100 mg/dL) and a blood pressure (BP) target of...
- 9From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground This study investigates the associations between changes in serum Triglycerides (S-TG), -Urate (S-Urate), and -Glucose (S-Glu) and changes in serum Calcium (S-Ca), -Magnesium (S-Mg), and -Phosphate (S-P)...
- 10From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Adipocyte fatty acid-binding protein (A-FABP) has been reported to play critical roles in the development of atherosclerosis. We investigated whether an increased in plasma A-FABP level can be...
- 11From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Carvedilol has been shown to be superior to metoprolol tartrate to improve clinical outcomes in patients with heart failure (HF), yet the mechanisms responsible for these differences remain unclear. We...
- 12From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Heart type fatty acid binding protein (H-FABP) has been closely associated with acute coronary syndrome, cardiac abnormalities, stroke, and obstructive sleep disorder in previous studies. The aim of this...
- 13From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Osteoprotegerin (OPG), a soluble member of the tumor necrosis factor receptor superfamily, is linked to cardiovascular disease. Negative associations exist between circulating OPG and cardiac function. The...
- 14From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground The prognostic value of hemoglobin A1c (HbA1c) in coronary artery disease (CAD) remains controversial. Herein, we conducted a systematic review to quantify the association between elevated HbA1c levels and...
- 15From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Adipokines contribute directly to the atherosclerotic process, connecting metabolic disorders such as obesity and diabetes to cardiovascular disease. Omentin-1 is a recently discovered novel adipokine, so...
- 16From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Although European guidelines advise oral glucose tolerance test (OGTT) in patients with acute myocardial infarction (AMI) before or shortly after hospital discharge, data supporting this recommendation are...
- 17From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground It has been shown that dendritic cells (DCs) and fractalkine play a role in accelerating progression of the inflamed atherosclerotic lesions and plaque rupture. We evaluated the numbers and functional...
- 18From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Elevated plasma levels of asymmetric dimethylarginine (ADMA) has been reported to be associated with insulin resistance and micro/macrovascular diabetic complications, and may predict cardiovascular events...
- 19From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground High glucose can induce apoptosis in vascular endothelial cells, which may contribute to the development of vascular complications in diabetes. We evaluated the role of the death receptor pathway of...
- 20From: Cardiovascular Diabetology. (Vol. 10) Peer-ReviewedBackground Aspirin has been recommended for the prevention of major adverse cardiovascular events (MACE, composite of non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death) in diabetic patients...